Knowledge Hub
The GRIPonMASH Knowledge Hub is designed to bring together everything you need to stay informed about MASLD and MASH.
Empowering through knowledge
In this space, you’ll find an overview of our peer-reviewed publications, practical educational resources, and a growing collection of media such as explainer videos, podcasts, and infographics. Our aim is to make complex information accessible and to provide healthcare professionals, researchers, and other stakeholders with tools that support awareness, early detection, and better treatment of these liver diseases.
Who are we doing this for?
Patients
…to better understand MASLD and MASH, what these conditions mean, and why early detection matters.
Healthcare Providers
…to access scientific publications, clinical resources, and practical tools that support diagnosis, screening, and treatment.
General Public
…to raise awareness, share knowledge, and encourage conversations about liver health and prevention.
Publications
Rationale and Design of a Prospective Multicenter Study
Global Research Initiative for Patient Screening on MASH (GRIPonMASH) protocol.The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) may be as high as 38% in the adult population with potential serious complications, multiple co-morbidities and a high socioeconomic burden.
Trainings
Interactive Factsheet
This e-learning module will cover Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). Participants will learn about their definitions, risk factors, health implications, early detection, and management/treatment strategies.
Media
What is MASH?
In this video, Dr. Onno Holleboom, MD, PhD, and Co-Lead of GRIPonMASH Work Package 1, outlines what MASH is, why it matters, and how early detection and lifestyle changes can make a significant difference. Watch the video to gain a clear understanding of MASH and why
urgent action is needed.
urgent action is needed.
Medicast Podcast
In this episode, we shed light on MASLD (metabolic dysfunction-associated steatotic liver disease), a condition more common than many realize. Early detection is crucial to prevent progression to MASH, cirrhosis, or liver cancer. Experts from GRIPonMASH share
their insights and perspectives.
their insights and perspectives.
What are MASLD and MASH? (Infographic)
This infographic breaks down what MASLD and MASH are, how they develop, and the key risk factors to look out for. It also highlights why early detection and timely intervention are essential in helping to prevent progression to more severe conditions.
